Key stats
About First Trust Health Care AlphaDEX
Expense ratio
0.62%
Home page
Inception date
May 8, 2007
FXH tracks a quant-driven index that attempts to achieve excess returns by selecting health care stocks based on growth and value factors, and equal-weighting them in tiers. The portfolio offers noteworthy mid-cap exposure, downplaying familiar large-cap names relative to cap-weighted peer funds. Additionally, FXH underweights pharmaceuticals relative to the market, but allows a significant exposure to biotechnology and healthcare providers. Overall, this fund offers a smart beta approach to the US health care space, tilting away from big pharma and towards other facets of health care. The index is reconstituted and rebalanced on a quarterly basis.
Classification
Returns
| 1 month | 3 months | Year to date | 1 year | 3 years | 5 years | |
|---|---|---|---|---|---|---|
| Price performance | — | — | — | — | — | — |
| NAV total return | — | — | — | — | — | — |
What's in the fund
Exposure type
Health Technology
Health Services
Stocks99.48%
Health Technology63.47%
Health Services25.83%
Commercial Services5.16%
Distribution Services3.15%
Technology Services1.14%
Producer Manufacturing0.73%
Bonds, Cash & Other0.52%
Miscellaneous0.38%
Mutual fund0.14%
Stock breakdown by region
North America100.00%
Latin America0.00%
Europe0.00%
Asia0.00%
Africa0.00%
Middle East0.00%
Oceania0.00%
Top 10 holdings
Dividends
Dividend payout history